Sánchez-Puig Juana M, Sánchez Laura, Roy Garbiñe, Blasco Rafael
Departamento de Biotecnología-I.N.I.A. Ctra. La Coruña km 7.5 E-28040, Spain.
Virol J. 2004 Nov 22;1:10. doi: 10.1186/1743-422X-1-10.
Vaccinia virus, the prototype member of the family Poxviridae, was used extensively in the past as the Smallpox vaccine, and is currently considered as a candidate vector for new recombinant vaccines. Vaccinia virus has a wide host range, and is known to infect cultures of a variety of cell lines of mammalian origin. However, little is known about the virus tropism in human leukocyte populations. We report here that various cell types within leukocyte populations have widely different susceptibility to infection with vaccinia virus.
We have investigated the ability of vaccinia virus to infect human PBLs by using virus recombinants expressing green fluorescent protein (GFP), and monoclonal antibodies specific for PBL subpopulations. Flow cytometry allowed the identification of infected cells within the PBL mixture 1-5 hours after infection. Antibody labeling revealed that different cell populations had very different infection rates. Monocytes showed the highest percentage of infected cells, followed by B lymphocytes and NK cells. In contrast to those cell types, the rate of infection of T lymphocytes was low. Comparison of vaccinia virus strains WR and MVA showed that both strains infected efficiently the monocyte population, although producing different expression levels. Our results suggest that MVA was less efficient than WR in infecting NK cells and B lymphocytes. Overall, both WR and MVA consistently showed a strong preference for the infection of non-T cells.
When infecting fresh human PBL preparations, vaccinia virus showed a strong bias towards the infection of monocytes, followed by B lymphocytes and NK cells. In contrast, very poor infection of T lymphocytes was detected. These finding may have important implications both in our understanding of poxvirus pathogenesis and in the development of improved smallpox vaccines.
痘苗病毒是痘病毒科的原型成员,过去被广泛用作天花疫苗,目前被认为是新型重组疫苗的候选载体。痘苗病毒具有广泛的宿主范围,已知能感染多种哺乳动物来源的细胞系培养物。然而,关于该病毒在人白细胞群体中的嗜性了解甚少。我们在此报告,白细胞群体中的各种细胞类型对痘苗病毒感染的易感性差异很大。
我们通过使用表达绿色荧光蛋白(GFP)的病毒重组体以及针对外周血淋巴细胞(PBL)亚群的单克隆抗体,研究了痘苗病毒感染人PBL的能力。流式细胞术可在感染后1 - 5小时内鉴定出PBL混合物中的感染细胞。抗体标记显示不同细胞群体的感染率差异很大。单核细胞的感染细胞百分比最高,其次是B淋巴细胞和自然杀伤(NK)细胞。与这些细胞类型不同,T淋巴细胞的感染率较低。痘苗病毒WR株和MVA株的比较表明,尽管二者产生的表达水平不同,但都能有效感染单核细胞群体。我们的结果表明,MVA在感染NK细胞和B淋巴细胞方面不如WR有效。总体而言,WR和MVA均始终表现出对非T细胞感染的强烈偏好。
在感染新鲜的人PBL制剂时,痘苗病毒对单核细胞感染表现出强烈偏好,其次是B淋巴细胞和NK细胞。相比之下,检测到T淋巴细胞的感染非常少。这些发现可能对我们理解痘病毒发病机制以及改进天花疫苗的开发都具有重要意义。